Effects of nitidine chloride on ulcerative colitis in mice and its mechanism

Ya-Li Wu1,2, Xin Liu1,2, Kai-Li Liu1,2

  • 1Department of Cell Physiology, Shanxi Medical University.

Abstract

Insights

Nitidine chloride (NC) effectively treats dextran sodium sulfate (DSS)-induced ulcerative colitis (UC) in mice. NC reduces disease activity and inflammation by down-regulating miR-31 expression, offering a potential therapeutic strategy for UC.

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Molecular Biology

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease with limited treatment options.
  • Dextran sodium sulfate (DSS)-induced colitis in mice is a widely used model to study UC pathogenesis and test potential therapies.
  • MicroRNAs (miRNAs) play crucial roles in regulating inflammatory responses and are implicated in UC.

Purpose of the Study:

  • To investigate the protective effects of nitidine chloride (NC) against DSS-induced UC in a mouse model.
  • To elucidate the underlying mechanisms of NC's action, focusing on the role of miR-31.
  • To evaluate the impact of NC on key inflammatory markers.

Main Methods:

  • Ulcerative colitis was induced in C57BL/6 mice using 1% DSS in drinking water.
  • Mice were divided into four groups: control, DSS, DSS + NC, and NC.
  • NC was administered via gavage, and disease activity index (DAI), colonic pathology (HE staining), miR-31 expression (qPCR), and protein levels of NF-κB and COX-2 (Western blot) were assessed.

Main Results:

  • NC treatment significantly decreased the DAI and ameliorated colonic pathological injury in DSS-induced colitis mice.
  • DSS administration led to a significant increase in miR-31 expression in colonic tissue, which was reduced by NC treatment.
  • NC significantly downregulated the expression of inflammatory proteins NF-κB and COX-2 in the colons of DSS-treated mice.

Conclusions:

  • Nitidine chloride exhibits significant therapeutic effects on DSS-induced ulcerative colitis in mice.
  • The anti-inflammatory mechanism of NC involves the down-regulation of miR-31 expression.
  • NC demonstrates potential as a novel therapeutic agent for ulcerative colitis.

Related Concept Videos